Katalin Szilagyi Nee Farago

This inventor holds 5 USPTO granted patents. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1979-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katalin Szilagyi Nee Farago. Retrieved from https://idiyas.com/inventor/katalin-szilagyi-nee-farago

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

5 out of 346

Richter Gedeon Vegyeszeti Gyar Rt

patents

Years Active: 1979-1987

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4668437 - Novel 20 benzcylamino pregnene derivatives and process for preparing same (1987-05-26),

2. 4342754 - Steroid-spiro-oxathiazolidine derivatives and a process for the (1982-08-03),

3. 4328221 - Substituted steroid-spiro-oxazolidinone derivatives and a process for (1982-05-04),

4. 4218446 - Substituted steroid-spiro-oxazolidinone derivatives and a process for (1980-08-19),

5. 4180505 - Novel steroidspirooxazolidines and process for their preparation (1979-12-25),

Title: Katalin Szilagyi Nee Farago: Pioneering Inventor in Pharmaceutical Innovations

Introduction: Katalin Szilagyi Nee Farago is an accomplished inventor based in Budapest, Hungary. With a remarkable portfolio of five patents, she has significantly contributed to the field of pharmaceutical chemistry. Her innovations focus on the development of novel derivatives with potential therapeutic applications.

Latest Patents: Among her latest patents, Katalin has developed novel 20 benzylamino pregnene derivatives, which provide new avenues for the treatment of various health conditions. This invention pertains to structurally distinct pregnene derivatives characterized by a unique general formula, potentially enhancing medicinal properties. Furthermore, she has also worked on steroid-spiro-oxathiazolidine derivatives and their pharmaceutical compositions, which exhibit antimineral corticoid effects. The innovative compounds described in this patent are identified by a specific formula that showcases a combination of alkyl and alkenyl groups.

Career Highlights: Katalin has made significant strides in her career at Richter Gedeon Vegyeszeti Gyar Rt, a leading pharmaceutical company in Hungary. Her research and patent contributions have positioned her as a key player in the biotech and pharmaceutical sectors, fostering advancements that strive to improve patient outcomes through innovative drug design.

Collaborations: In her journey as an inventor, Katalin has collaborated with esteemed coworkers including Inge Schafer and Eleonora Szondy. These partnerships have enabled interdisciplinary approaches to research and development, further enhancing the impact of their collective work in the pharmaceutical industry.

Conclusion: Katalin Szilagyi Nee Farago’s contributions to the realm of pharmaceutical innovations through her patents demonstrate her commitment to enhancing healthcare solutions. With a strong foundation in scientific research and a collaborative spirit, she continues to pave the way for future advancements in medicinal chemistry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]